The Latest Headlines at The Lincolnian Online
What POSCO (PKX) Said on Its Q3 Earnings Call
POSCO (NYSE:PKX) Holdings reported third-quarter revenue of KRW 19.1 trillion and operating profit of KRW 945 billion, extending a three-quarter improvement in earnings as stronger steel profitability offset losses in lithium-related... More of this article »
What TAT Technologies (TATT) Said on Its Q3 Earnings Call
TAT Technologies (NASDAQ:TATT) reported record third-quarter 2026 revenue and adjusted EBITDA, as demand in its auxiliary power unit, or APU, business, heat exchangers and trading, leasing and distribution operations supported growth... More of this article »
Head-To-Head Survey: Healthcare Realty Trust (NYSE:HR) versus Omega Healthcare Investors (NYSE:OHI)
Omega Healthcare Investors (NYSE:OHI – Get Free Report) and Healthcare Realty Trust (NYSE:HR – Get Free Report) are both real estate companies, but which is the superior stock? We will contrast the two businesses based... More of this article »
Conagra Brands (CAG) vs. The Competition Financial Analysis
Conagra Brands (NYSE:CAG – Get Free Report) is one of 328 public companies in the “Food Products” industry, but how does it contrast to its peers? We will compare Conagra Brands to related businesses based on the... More of this article »
Stephens Has Lowered Expectations for Dutch Bros (NYSE:BROS) Stock Price
Dutch Bros (NYSE:BROS – Get Free Report) had its price objective reduced by research analysts at Stephens from $65.00 to $47.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has... More of this article »
What ESAB (ESAB) Said on Its Q3 Earnings Call
ESAB (NYSE:ESAB) reported higher third-quarter sales and adjusted earnings before interest, taxes, depreciation and amortization, helped by acquisitions and organic growth in both of its reporting segments. The company also updated... More of this article »
Adaptive Biotechnologies (ADPT) & Its Peers Head-To-Head Review
Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) is one of 109 publicly-traded companies in the “Life Sciences Tools & Services” industry, but how does it weigh in compared to its rivals? We will compare... More of this article »
Vodafone Group (NASDAQ:VOD) Stock Rating Raised to Hold at Zacks Research
Zacks Research upgraded shares of Vodafone Group (NASDAQ:VOD – Free Report) from a strong sell rating to a hold rating in a research report sent to investors on Tuesday,Zacks reports. Other equities research analysts have also... More of this article »
Kimberly-Clark (NASDAQ: KMB) closes Kenvue deal, but organic sales slip 1.3%
What happened Kimberly-Clark Corporation (NASDAQ: KMB) reported third-quarter 2026 results days after it completed the Kenvue acquisition. Organic sales fell 1.3%. The core business lost sales momentum, with a China social media disruption... More of this article »
Reviewing CF Bankshares (NASDAQ:CFBK) & Bankinter (OTCMKTS:BKNIY)
CF Bankshares (NASDAQ:CFBK – Get Free Report) and Bankinter (OTCMKTS:BKNIY – Get Free Report) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their... More of this article »
Charles River Laboratories International Q3 Earnings Call Highlights
Charles River Laboratories International (NYSE:CRL) raised its 2026 revenue and earnings outlook after third-quarter organic revenue growth accelerated to 4.7%, supported by demand for safety assessment and manufacturing testing services. Non-GAAP... More of this article »
IceCure Medical (NASDAQ:ICCM) and TransMedics Group (NASDAQ:TMDX) Financial Comparison
TransMedics Group (NASDAQ:TMDX – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength... More of this article »
ADMA Biologics (NASDAQ:ADMA) Stock Price Target Raised at Cantor Fitzgerald
ADMA Biologics (NASDAQ:ADMA – Get Free Report) had its target price hoisted by equities research analysts at Cantor Fitzgerald from $12.00 to $13.00 in a report released on Thursday, Benzinga reports. The brokerage presently... More of this article »